24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
09/02/2017
Hepatitis C Under the Watchful of ALBA Synchrotron
02/02/2017
The Barcelona Entrepreneurial Spirit Attracts Important Rounds of Funding
26/01/2017
SENER, 50 Years In Space!
19/01/2017
Barcelona Synchrotron Park Even Closer
11/01/2017
ALBA Synchrotron Is Also a Tool for the Environment
05/01/2017
Barcelona & Catalonia Startup Hub, the Catalan startups showcase